William M. Lydiatt, MD, FACS

• Professor and Vice Chair, Department of Otolaryngology
• Director of Head and Neck Surgery
• University of Nebraska Medical Center
• Professor, Department of Head and Neck Surgery
• Nebraska Methodist Hospital
• Omaha, Nebraska

Such adaptation is possible only in the short term because the body may not always be able to adequately enhance respiration hiv infection muscle pain buy starlix 120mg overnight delivery. Erythrocytosis is considered to be a universal hiv infection rates by city buy starlix 120mg online, uniform adaptation response to hypoxia that arises in normal individuals antiviral used for meningitis order online starlix, but when it is exaggerated hiv infection virus buy genuine starlix, in some cases hiv infection in toddlers cheap 120mg starlix visa, it results in chronic mountain sickness with associated symptoms of fatigue how long after hiv infection will symptoms appear order generic starlix from india, headache, and pulmonary hypertension. Polyakova, described erythrocytosis in the Chuvash population (an ethnic isolate in the mid-Volga River region of Russia of Turkish descent) in the early 1960s,66 and by 1974, 103 cases from 81 families had been described. It is congenital and manifests autosomal dominant inheritance3 and, frequently, sporadic occurrence from de novo germline mutations, attesting to its deleterious effect. Deleterious mutations keep their prevalence by de novo mutations as exemplified by the high rate of de novo mutations in hemophilia A (Chap. The interaction leads to phosphorylation of the receptor and initiates a cascade of signaling that ultimately results in erythroid progenitor proliferation and differentiation. This interaction dephosporylates the receptor and turns off the signaling resulting in cessation of erythroid progenitor proliferation. In the normovolemic state, viscosity increases in a log-linear fashion as Hct increases, and the effect is particularly pronounced when the Hct rises above 50%. The prediction is that oxygen delivery decreases as Hct rises significantly above 50 because the greatly increased viscosity reduces blood flow, overshadowing the increased oxygen-carrying capacity of blood with a higher concentration of Hb. However, erythrocytosis is not a normovolemic state but is accompanied by an increase in blood volume, which in turn enlarges the vascular bed and decreases peripheral resistance (Chaps. Thus, hypervolemia can increase oxygen transport, and the optimum for oxygen transport occurs at higher Hct values than in normovolemic states. Consequently, despite the attendant increase in viscosity, an increase in Hct may generally be of benefit in compensatory secondary erythrocytoses. However, at some point, the high viscosity causes an increase in the work of the heart and a reduction in blood flow to most tissues and may be responsible for cerebral and cardiovascular impairment. The initial oxygen gradient between atmospheric and alveolar air can be reduced by an increase in respiratory rate and volume. Because dead space and water vapor pressure are constant and acclimatized individuals do not ventilate excessively, the normal sea-level gradient of about 60 mm Hg (torr) is only reduced to about 40 torr in Morococha at 4540 m (14,900 ft) above sea level. A shift in the oxygen dissociation curve to the right, which represents decreased affinity of Hb for oxygen, may be of benefit for short-term high-altitude acclimatization,77 but its usefulness for chronic acclimatization has probably been exaggerated. In chronic acclimatization, blood pH is slightly increased, and when this is taken into account, the dissociation curve is shifted approximately to normal. Furthermore, native Andean high-altitude dwellers have a gradual increase in their Andean highlanders living at 5500 m than in Page 7 / 38, Josef T. In chronic acclimatization, blood pH is Countway Medical Library Access Provided by: slightly increased, and when this is taken into account, the dissociation curve is shifted approximately to normal. There is a relationship between higher altitude and Hb concentration response, best studied among Andean highlanders and Europeans in the United States; Hb concentration is almost 10% higher in Andean highlanders living at 5500 m than in those living at 4355 m. Furthermore, native Andean high-altitude dwellers have a gradual increase in their Hb levels with age81 and body weight. The oxygen gradient from atmospheric air to the tissues in individuals living at sea level and in Morococha, Peru, at 4540 m (14,900 ft) above sea level. In a subset of Andean high-altitude native dwellers, namely Quechuas and Aymaras, erythrocytosis becomes excessive and often results in chronic mountain sickness with its associated constitutional symptoms and pulmonary hypertension. Andean highlanders have higher oxygen saturation than Tibetans at the same altitudes. This effect may improve oxygen delivery by inducing vasodilatation and increasing blood flow to tissues, thus making the compensatory increase in red cell volume unnecessary. Although Ethiopian high-altitude dwellers have Hb concentrations that fall in the normal range (15. Their cerebral circulation is increased but is insensitive to hypoxia, unlike Peruvian high-altitude dwellers. Both of these haplotypes were shown to be associated with differences in Hb despite the decrease in ambient oxygen tension at high altitude. Two of these selected regions include genes that have undergone the strongest genetic selection and are thus likely the most beneficial for Tibetan adaptation. Both of these haplotypes were shown to be associated with differences in Hb concentration at high altitude by several independent studies. Most high-altitude dwellers do not have measurable levels or a history of exposure to cobalt or other heavy metals. This has been attributed to infections and inflammation often present in the lungs, resulting in anemia of chronic inflammation, and to an increase in plasma volume. Why some patients with lung disease and congenital heart disease develop erythrocytosis but others do not is not entirely clear. Erythrocytosis of Eisenmenger Syndrome Patients with right-to-left shunting (Eisenmenger syndrome) develop a degree of erythrocytosis comparable to that observed with similar degrees of desaturation at high altitudes. Erythrocytosis is present in most patients, but excessive phlebotomy may cause microcytosis, and some have attributed this effect to the exacerbation of the symptoms of hyperviscosity. A correction for this effect has been calculated and is labeled affinity correction. The adjusted hemoglobin indicates the blood concentrations that would be present in the subjects in the absence of excess carbon monoxide. Erythrocytosis Secondary to High-Affinity Hemoglobins Hemoglobins with certain amino acid substitutions manifest an increased affinity for oxygen, producing tissue hypoxia and compensatory erythrocytosis (Chap. Mutations affecting amino acids of the 12 globin chain interface affect normal rotation within molecules and impair the rate of deoxygenation. Changes in the carboxyl terminal and penultimate amino acids also impair intramolecular motion and tend to keep molecules in a high-affinity state. Most hemoglobins with a mutation involving amino acids in the heme pocket are unstable and are associated with hemolytic anemia and cyanosis. High-affinity hemoglobins result from mutations in any of three globin genes; those from -globin gene mutations are congenital and lifelong. Occasionally, mild erythrocytosis occurs in patients with methemoglobinemia because of cytochrome b5 reductase (methemoglobin reductase) deficiency (Chap. Occasionally, Access Provided by: mild erythrocytosis occurs in patients with methemoglobinemia because of cytochrome b5 reductase (methemoglobin reductase) deficiency (Chap. Because these mutations are very rare, with only a single family comprehensively studied,112 it is not clear if the mode of inheritance is recessive or dominant. This condition, as well as other high-affinity hemoglobins, can only be conclusively confirmed by direct measurement of a Hb dissociation curve, conveniently expressed as the partial pressure of oxygen required to saturate 50% of Hb (p50 O2); when equipment for this is not available, p50 can be estimated from pH, pO2 and Hb oxygen saturation of venous blood. The erythrocytosis may become excessive and even symptomatic, especially in infants of mothers with diabetes or if clamping of the cord is delayed, permitting placental blood to boost the blood volume of the infant. This dramatic decrease of Hct in neonates during their first days of life contributes to neonatal jaundice (Chap. The condition is caused by an abnormality in the oxygen-sensing pathway and causes thrombotic and hemorrhagic vascular complications that lead to early mortality; survival beyond age 65 years is uncommon. Surprisingly, these changes were associated with either erythrocytosis or tumors, but not both, in the same family. This observation was later extended to Afghan and Northern and Southern Indian populations. Such an advantage might be related to a subtle improvement of iron metabolism, erythropoiesis, embryonic development, energy metabolism,137 or some other as yet unknown effect. Indeed, heterozygotes were shown to be less likely to be anemic compared with control participants. The tumors result from a somatic mutation in addition to the germline mutation (ie, loss of heterozygosity). It is not clear why mutations of a single gene lead to these two diverse phenotypes. Whether the cause of erythrocytosis in this case is haploinsufficiency or a dominant negative effect remains to be determined. Further studies of the molecular basis revealed a complex mechanism for this observation. These investigators then found a similar phenomenon in an unrelated polycythemic family with a deletion of nucleotide C in the same exon. Some such families show dominant inheritance,148 but in others, inheritance is recessive, and in some, it is sporadic. In some patients on prolonged dialysis treatment, cystic transformation occurs in the native kidneys. This acquired cystic disease is occasionally associated with marked erythrocytosis. Nevertheless, it has proved quite difficult to induce erythrocytosis in laboratory animals by placing a Goldblatt clamp on the renal arteries. Erythrocytosis with Connective Tissue Tumor Occasionally, there is an association of erythrocytosis with large uterine myomas. Brain Tumors In adequately studied patients with erythrocytosis and cerebellar hemangiomas, arterial blood gas tensions have been normal. Hepatoma Access Provided by: In 1958, McFadzean and coworkers reported that almost 10% of patients in Hong Kong with hepatocellular carcinoma developed erythrocytosis. Absence of a sufficient level of this mutation in the peripheral blood makes this syndrome particularly difficult to diagnose prior to the onset of syndrome-associated tumors. Mild erythrocytosis may be present in patients with Cushing syndrome, but its pathophysiological basis is not entirely clear (Chap. It was not until pharmacologic doses of testosterone were administered to women with carcinoma of the breast that the full erythropoietic potency of androgens was appreciated. Erythropoietic response to testosterone derivatives in a patient with myelofibrosis. Access Provided by: Erythropoietic response to testosterone derivatives in a patient with myelofibrosis. Others suggest that it is caused by a primary reduction in plasma volume and have associated it with hypertension, obesity, and stress. When the red cell mass is documented to be normal, spurious erythrocytosis is also an appropriate term. The high Hct with its associated high viscosity is believed by some to be a risk factor heralding cerebral and cardiac complications, but others believe it is merely a well-tolerated anomaly. Because the designation apparent erythrocytosis183 is noncommittal, it is used here. The main clinical associations with apparent erythrocytosis are obesity, hypertension, and smoking. In obese patients, the finding of a normal red cell volume may be spurious because if the volume is expressed in terms of lean body weight, some of these patients would have a significant increase in red cell mass. In hypertensive patients, there is no adequate explanation for the apparent increase in red cell production or decrease in plasma volume. Chronic administration of diuretics to treat hypertension may be a more likely cause. Chronic Countway Medical Library administration of diuretics to treat hypertension may be a more likely cause. Unless exposed to alkylating agents or radioactive phosphorus, as many have been, these patients do not progress to acute leukemia or myelodysplastic syndrome. Hypertension, coronary artery disease, and strokes have been reported but do not clearly appear to be related to an elevated Hct because they also occur in aggressively phlebotomized patients with normal Hct191 and are not a constant feature of the disorder. Chuvash erythrocytosis is also associated with thrombosis, relatively low blood pressure (also seen in heterozygotes), and varicose veins. During the prospective 11-year observation period, 37 new events occurred in 33 Chuvash erythrocytosis participants (9 of which were fatal), and 6 new events developed in 4 control participants. A history of therapeutic phlebotomy was associated with an increased risk of thrombosis in both univariate (hazard ratio, 2. This suggests that the thrombotic risk may be independent of elevated Hct and viscosity but rather related to the upregulated hypoxic responses associated with this congenital disorder. Benign vertebral body hemangiomas (a distinct entity from hemangioblastoma) were found in significantly more patients with Chuvash erythrocytosis compared with control participants (55% vs. Imaging studies of 33 Chuvash erythrocytosis patients revealed unsuspected cerebral ischemic lesions in 45% of patients. Over the past 2 decades, we observed a high rate of thrombotic complications (stroke, myocardial infarction, deep vein thrombosis, and Budd-Chiari syndrome).

Syndromes

• Breathing difficulty (from breathing in substance)
• Fibrocystic breast (normal lumpiness in the breast)
• Manage the diarrhea
• Eye blinking
• Collapsed lung
• Right-sided heart failure
• Blood in the stool
• Nifedipine (Procardia)

The importance of haemogram parameters in the diagnosis and prognosis of septic patients hiv infection age group generic 120mg starlix amex. Monocyte distribution width: a novel indicator of sepsis-2 and sepsis-3 in high-risk emergency department patients antivirus windows vista buy 120mg starlix with visa. It usually results from decreased production of neutrophil precursor cells in the marrow hiv infection detection starlix 120 mg free shipping. Neutropenia also can result from a shift of neutrophils from the circulating into the marginated cell pools in the circulation hiv infection rate in peru generic starlix 120 mg overnight delivery. Less commonly antiviral quizlet purchase starlix 120 mg amex, neutropenia results from accelerated destruction of neutrophils or increased egress of neutrophil from the circulation into the tissues hiv infection cold symptoms discount starlix 120 mg otc. When neutropenia is the sole or dominant abnormality, the condition is called "selective" or "isolated" neutropenia, such as severe congenital neutropenia, chronic idiopathic neutropenia, or drug-induced neutropenia. Neutropenia can occur in other inherited or acquired marrow failure syndromes, such as severe aplastic anemia or Fanconi anemia, in which the condition is a bicytopenia or pancytopenia. In some diseases, several cell lineages are mildly affected, but the reduction in neutrophils is the most severe, such as Felty syndrome. Neutropenia may be an indicator of an underlying systemic disease, such as early cobalamin or transcobalamin deficiency. Demargination of neutrophils or rapid release of neutrophils from the normally large marrow pool transiently increases the blood neutrophil count. Neutrophilia contributes to the inflammatory response and to resolution of infections. Inflammatory and infectious diseases are the most frequent causes of neutrophilia. Bacterial infections usually produce neutrophilia, whereas viral infections may not produce neutrophilia or may raise the neutrophil count only slightly. Chronic myeloid leukemia and chronic neutrophilic leukemia usually cause sustained neutrophilia. Agranulocytosis literally means a complete absence of blood granulocytes, but this term often is used to indicate severe neutropenia, that is, counts less than 0. Age, activity, and genetic and environmental factors influence the concentration of neutrophils in blood (Chap. For individuals older than age 10 years, neutropenia is defined as a count less than approximately 1. Healthy older persons have the same blood neutrophil counts as younger individuals (Chap. Some racial and ethnic groups, such as Africans, African Americans, and Yemenite Jews, have lower mean neutrophil counts than persons of Asian or European ancestry (see Chap. In persons of African descent, neutropenia is associated with the Duffy null phenotype. Neutropenia resulting from disorders of production that affect early hematopoietic precursor cells (eg, aplastic anemia, severe congenital neutropenia) leads to greater susceptibility to infections than do conditions with normal or near normal neutrophils in the marrow (eg, rheumatoid arthritis, Felty syndrome, autoimmune neutropenia). Neutropenia accompanied by monocytopenia, lymphocytopenia, or hypogammaglobulinemia is more serious than isolated neutropenia. The risk of infections is inversely related to the severity of the neutropenia (Chap. Other factors, such as the integrity of the skin and mucous membranes, the vascular supply to tissues, and the nutritional status of the patient, also influence the risk of infections. Some production disorders are caused by intrinsic abnormalities of hematopoietic progenitor cells (Chap. Other disorders in cell production are caused by extrinsic factors, including changes in the marrow environment, such as tumor infiltration, fibrosis, or irradiation (Chap. Production of neutrophils is defined as ineffective when, under a steady state of hematopoiesis, there are a relative abundance of early neutrophil precursors and a paucity of late-maturing cells. This condition has often been referred to as "maturation arrest," but it is almost always explained by either the apoptotic loss of precursors in the marrow or as an intrinsic defect in cell maturation. Less commonly it is caused by rapid release of segmented neutrophils because of exaggerated tissue demands. The rate of flow of cells through each compartment is represented by the size of the arrows. The rate Access Provided by:through each of flow of cells compartment is represented by the size of the arrows. Accelerated neutrophil utilization occurs with autoimmune neutropenia (see later) and acute bacterial infections. When rapid neutrophil utilization and impaired production occur, acute severe neutropenia often develops. The condition is illustrated by the abrupt and sustained fall in neutrophils when a patient with alcoholism develops pneumococcal pneumonia. Alcohol suppresses the marrow, and the infection consumes the available neutrophil supply. After myelotoxic cancer chemotherapy, the abrupt fall in blood neutrophils at the onset of infections reflects a similar mechanism: high demand and limited supply. With idiosyncratic druginduced neutropenia, the counts may fall abruptly because both blood and marrow cells are simultaneously damaged. The cells reenter the circulating pool, and the blood supply of neutrophils is rapidly restored from the large reserves of marrow neutrophils entering the blood. Neutropenia also occurs with enlargement of the spleen, usually attributed to sequestration without necessarily destruction. This occurs acutely in malaria and other infectious diseases and chronically with hepatosplenomegaly in patients with cirrhosis and autoimmune diseases. Cellular and Molecular Mechanisms of Neutropenia Our understanding of the mechanisms of neutropenia at the cellular and molecular levels is increasing rapidly because of advances in molecular genetics and cell biology. Some mutations and acquired defects shorten the survival of the precursor cells, that is, they accelerate apoptosis. This form of cell loss now considered to be the mechanism for "maturation arrest" in several congenital disorders of myelopoiesis. Gene Mutations in Congenital Neutropenia Page 3 / 26 Cellular and Molecular Mechanisms of Neutropenia Our understanding of the mechanisms of neutropenia at the cellular and molecular levels is increasing rapidly because of advances in molecular genetics and cell Access Provided by: Countway Medical Library biology. Neutrophils can also be depleted from the blood and the marrow as a result of extrinsic factors such as antineutrophil antibodies and toxic cytokines generated by other cells. Susceptibility to infection in these conditions relates to the combination of defects. Not every condition fits neatly into this scheme, but it provides a framework for understanding these diverse disorders. Disorders of Production Cytotoxic drugs given for cancer chemotherapy and as immunosuppressive agents regularly cause neutropenia by decreasing cell production (Chap. Neutropenia as a result of impaired production is also a common feature of diseases affecting hematopoietic stem cells, such as acute leukemia (Chaps. The selective causes of impaired production, progressing from disorders of early precursors to disorders presumed to involve defective maturation (ineffective production), are described briefly as follows. In these patients, symptoms and signs of otitis, gingivitis, pneumonia, enteritis, peritonitis, and bacteremia usually begin in the first months of life. Characteristically, the marrow shows early neutrophil precursors (myeloblasts, promyelocytes) but few or no myelocytes or mature neutrophils. Usually blood lymphocyte numbers are normal, immunoglobulin (Ig) levels are normal or increased, and lymphocyte functions are intact. Mutations in neutrophil elastase cause the unfolded protein response in the endoplasmic reticulum and initiate apoptotic cell death. Morphology of a marrow sample from a patient with congenital neutropenia showing the maturation arrest at the level of promyelocytes. Countway Medical Library Access Provided by: Morphology of a marrow sample from a patient with congenital neutropenia showing the maturation arrest at the level of promyelocytes. The marrow morphology of patients harboring one of these mutations show a great variability in the deficiencies of granulocyte precursors. Hematopoietic transplantation is the only other therapy known to improve the clinical course for these patients. In most of these conditions, neutropenia is attributed to a production disorder based largely on histologic examination of the marrow. Neutropenia is particularly prominent in the rare immunodeficiency state, reticular dysgenesis. Each of these disorders causes neutropenia, anemia, and thrombocytopenia as a result of ineffective hematopoiesis (Chap. These cases often are called familial (benign) neutropenia and probably are autosomal dominant disorders. Some cases of chronic benign neutropenia of childhood (usually a negative family history) may represent new mutations, and patients with chronic idiopathic neutropenia of adulthood may be childhood cases escaping early detection. Until better information is available, these conditions probably are best referred to as "idiopathic neutropenias. The neutropenia often is severe with a high risk of infection, particularly for early-onset neonatal sepsis (ie, in the first 24 hours after birth). Copper deficiency can cause neutropenia in patients on total parenteral nutrition, patients with a history of gastrectomy, and malnourished children, and the bicytopenia or tricytopenias with a marrow showing dysplastic precursors can masquerade as myelodysplastic syndrome (Chap. The differential diagnosis includes aplastic anemia, myelodysplasia, and hairy cell leukemia. Immunosuppressive therapy with cyclosporine, sirolimus, antithymocyte globulin, and glucocorticoids have been used successfully in individual cases. Mild leukopenia and lymphocytopenia may be present, and the spleen is normal or only minimally enlarged. The patients have no chromosomal abnormalities or other evidence of myelodysplasia. Marrow examinations show a spectrum of abnormalities, ranging from normal cellularity to selective hypoplasia of the neutrophilic series. In most cases, quantitative marrow studies show the ratio of immature to mature cells is increased, suggesting loss of cells during the maturation process, that is, ineffective granulocytopoiesis. In general, patients with the lowest levels of blood and marrow neutrophils have the most frequent problems. Long-term observations show, however, that some patients have very low blood neutrophil levels for long periods with few or no infections. Dale Karl Welte demonstrates that cellular and humoral immune mechanisms can cause neutropenia (Chap. Antineutrophil antibodies cause transfusion reactions, alloimmune neonatal neutropenia, and autoimmune neutropenia. The association of neutropenia with increased numbers of circulating large granular lymphocytes demonstrates that cellular and humoral immune mechanisms can cause neutropenia (Chap. The agglutination tests are the oldest methods and depend on the propensity of Ig-coated cells to aggregate. These tests can be adapted for quantitative studies with fluorescence-activated cell sorting. Use of paraformaldehyde to expose antigens and to preserve the neutrophils for multiple tests has been especially helpful. Measurements of apoptosis and cytokine-mediated cellular injury are done through research laboratories. Causes of Immune-Mediated Neutropenia Alloimmune Neonatal Neutropenia Newborn infants may have neutropenia for a variety of reasons. It often is not recognized until bacterial infections occur in an otherwise healthy infant. The hematologic picture usually consists of severe neutropenia with normal to increased lymphocytes and normal monocytes, erythrocytes, and platelets. Marrow cellularity is normal or increased, with reduced numbers of mature neutrophils. Alloimmune neonatal neutropenia may be confused with neonatal sepsis because the latter condition also causes severe neutropenia. The diagnosis of alloimmune neutropenia usually is made using neutrophil agglutination or immunofluorescence tests. Autoimmune Neutropenia Neutrophil autoantibodies can decrease neutrophil survival and impair neutrophil production.

Order starlix now. Three HIV-infected sisters commit suicide.

Sudden death can occur in patients with hyperleukocytic acute leukemia as a result of intracranial hemorrhage hiv infection from dentist discount starlix 120 mg on line. Retinal vein distention hiv infection rate by country starlix 120mg line, retinal hemorrhages Chapter 82: Classification and Clinical Manifestations of the Clonal Myeloid Disorders hiv infection gas station discount starlix 120 mg fast delivery, Marshall A hiv infection how long does it take 120mg starlix with visa. Spurious laboratory results Page 20 / 31 reverses the hyperleukocytic syndrome and can reduce the extent of cytolysis-induced hyperuricemia hiv infection first 24 hours purchase 120mg starlix fast delivery, hyperkalemia antiviral drugs classification purchase 120 mg starlix with mastercard, and hyperphosphatemia by Countway Medical Library reducing tumor cell mass before hydroxyurea therapy. Decreased plasma glucose; increased mean corpuscular volume, red cell count, hemoglobin, and hematocrit Tumor Lysis Syndrome Tumor lysis syndrome is a consequence of rapid cell lysis, usually as a result of cytotoxic therapy, and the resultant release of potentially toxic intracellular contents, resulting in hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia. Although tumor lysis syndrome is associated with high-count leukemias and high-tissue-burden lymphomas, the use of more potent chemoradiotherapy regimens has led to the syndrome developing in circumstances in which dramatic increases in blood and tissue tumor cells are not present. It has been proposed that the risk can be predicted most accurately by the serum uric acid level. A discussion of prevention and therapy of tumor lysis syndrome can be found in Chap. Peripheral vascular insufficiency with gangrene and cerebral vascular thrombi can develop. Gastrointestinal hemorrhage and cutaneous hemorrhage, the latter especially after trauma, happen most frequently, but bleeding from other sites also can result (Chap. Lichtman Thrombotic complications occur in approximately 40% of patients with polycythemia vera. Erythrocytosis and thrombocytosis may interact and cause hypercoagulability, especially in the abdominal venous circulation. A syndrome of splanchnic venous manifestation of thrombocythemia and can occur concomitantly with thrombotic episodes. Gastrointestinal hemorrhage and cutaneous hemorrhage, Countway Medical Library the latter especially after trauma, happen most frequently, but bleeding from other sites also can result (Chap. A syndrome of splanchnic venous thrombosis associated with endogenous erythroid colony growth, the latter characteristic of polycythemia vera, but without blood cell count changes indicative of a myeloproliferative disease, has accounted for a high proportion of patients with apparent idiopathic hepatic or portal vein thrombosis. Thrombosis of the veins of the abdomen, liver, and other organs, characteristic complications of paroxysmal nocturnal hemoglobinuria, may result from a complex thrombophilic state related to nitric oxide depletion, formation of prothrombotic platelet microvesicles, the dysfunction of tissue factor pathway inhibitor, and other factors. If therapy is instituted without a reduction in plasma uric acid and without adequate hydration, saturation of the urine with uric acid can lead to precipitation of urate (gravel) and obstructive uropathy. If the uropathy is severe, urine flow can be obliterated, and renal failure ensues. Hyponatremia also can result from an osmotic diuresis of urea, creatinine, urate, and other substances released from blast cells and wasting muscles. Hypokalemia is related to excessive urinary potassium loss, but the correlation with lysozymuria is imperfect. Other mechanisms probably are responsible in most cases, including osmotic diuresis and tubular dysfunction. Several causes have been proposed, including bone resorption as a result of leukemic infiltration. This explanation is in keeping with the normal serum inorganic phosphate in most patients. Occasional patients with hypercalcemia and hypophosphatemia can have ectopic parathyroid hormone secretion by leukemic blast cells. Hypophosphatemia also can occur because of rapid utilization of plasma inorganic phosphate in some cases of myelogenous leukemia with a high blood blast cell count and a high fraction of proliferative cells. Hyperphosphatemia is uncommon, except as a reflection of the tumor lysis syndrome. True hypoxia can result from the hyperleukocytic syndrome as a consequence of pulmonary vascular leukostasis (see also "Factitious Laboratory Results" below). If blood is collected in a tube that contains an anticoagulant and the plasma is removed after high-speed centrifugation, the potassium concentration is normal. Glucose can be falsely decreased, especially because autoanalyzer techniques call for omission of glycolytic inhibitors such as sodium fluoride in collection tubes. Blood with high leukocyte counts, if it stands before separation of the plasma, may have a significant amount of glucose metabolism by leukocytes. Factitious hypoglycemia also can occur as a result of red cell utilization of glucose, especially in polycythemic patients. Arterial blood oxygen content also can be lowered spuriously as a result of in vitro utilization by large numbers of leukocytes, while the anticoagulated blood awaits measurement. Although clusters of cells may be found in all organs, major infiltrates and organ dysfunction are unusual. In essential thrombocythemia, splenic enlargement is present in approximately 30% of patients. A predisposition to silent splenic vascular thrombi, infarction, and subsequent splenic atrophy, analogous to that occurring in sickle cell anemia, is postulated as the cause of the lower frequency of splenic enlargement in essential thrombocythemia. In primary myelofibrosis, the spleen can become enormous, occupying the left hemiabdomen. Blood flow through the splenic vein can be so great as to lead to portal hypertension and gastroesophageal varices. Anemia and thrombocytopenia are very common, as are nucleated red cells and myelocytes in the blood (leukoerythroblastic reaction). Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Page 23 / 31 Chapter 82: Classification and Clinical Manifestations of the Clonal Myeloid Disorders, Marshall A. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Page 24 / 31 Chapter 82: Classification and Clinical Manifestations of the Clonal Myeloid Disorders, Marshall A. Does a diagnosis of myelogenous leukemia require 20% marrow myeloblasts, and does <5% marrow myeloblasts represent a remission Myelodysplasia or myeloneoplasia: thoughts on the nosology of clonal myeloid diseases. The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: An alternative proposal. Long-term outcomes of polycythemia vera patients treated with pipobroman as initial therapy. Polycythemia in young patients: A study on the long-term risk of thrombosis, myelofibrosis and leukemia. Age-related differences in disease characteristics and clinical outcomes in polycythemia vera. Is it chronic idiopathic myelofibrosis, myelofibrosis with myeloid metaplasia, chronic megakaryocytic-granulocytic myelosis, or chronic megakaryocytic leukemia Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: A preliminary assessment. Chronic myelomonocytic leukemia with antecedent refractory anemia with excess blasts: further evidence for the arbitrary nature of current classification systems. Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-ofcare diagnostic algorithms. Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Global gene expression in classification, pathogenetic understanding and identification of therapeutic targets in acute myeloid leukemia. Genes predictive of outcome and novel molecular classification schemes in adult acute myeloid leukemia. Gene expression profiling for the diagnosis and prognosis of acute myeloid leukemia. Analyzing transformation of myelodysplastic syndrome to secondary acute myeloid leukemia using a large patient database. Association of chemotherapy for solid tumors with development of therapy-related myelodysplastic syndrome or acute myeloid leukemia in the modern era. The stem cell in the pathogenesis and treatment of myelogenous leukemia: a perspective. Uncommon phenotypes of acute myelogenous leukemia: basophilic, mast cell, eosinophilic, and myeloid dendritic cell subtypes: a review. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis. Lineage involvement of stem cells bearing the Philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by combination of fluorescence-activated cell sorting and fluorescence in situ hybridization. Acute nonlymphocytic leukemia: expression in cells restricted to granulocytic and monocytic differentiation. Clonal origin of cells restricted to monocytic differentiation in acute nonlymphocytic leukemia. Clonality analysis of hematopoietic cell lineages in acute myeloid leukemia and trans-location (8;21): only myeloid cells are part of the malignant clone. Thomas D, Majeti R, Biology and relevance of human acute myeloid leukemia stem cells. Interrupting the inhibition of normal hematopoiesis in myelogenous leukemia: a hypothetical approach to therapy. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Peripheral cytoplasmic characteristics of leukemia cells in monocytic leukemia: relationship to clinical manifestations. Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia. Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Outcome of hyperleukocytic adult acute myeloid leukaemia: a single-center retrospective study and review of literature. Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study. Page 29 / 31 Chapter 82: Classification and Clinical Manifestations of the Clonal Myeloid Disorders, Marshall A. Pan-European multicentre economic evaluation of recombinant urate oxidase (rasburicase) in prevention and treatment of hyperuricaemia and tumour lysis syndrome in haematological cancer patients. Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with thrombocythemia. Hypercoagulability and tissue factor gene upregulation in hematologic malignancies. Hematologic causes of venous thrombosis in young people: high incidence of myeloproliferative disorder as underlying disease in patients with splanchnic venous thrombosis. Elevated lipoprotein (a) levels in patients with acute myeloblastic leukaemia decrease after successful chemotherapeutic treatment. Hyperprolactinemia in acute myeloid leukemia and indication of ectopic expression of human prolactin in blast cells of a patient of subtype M4. Hyperprolactinemia in acute myeloid leukemia and indication of ectopic expression Countway Medical Library of human prolactin in blast cells of a patient of subtype M4. Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia and lymphoid malignancies. Hyperprolactinemia in acute myeloid leukemia and indication of ectopic expression of human prolactin in blast cells of a patient with subtype M4. Bone marrow necrosis: clinicopathologic analysis of 20 cases and review of the literature. Primary polycythemias result from abnormal intrinsic properties of erythroid progenitors that proliferate independently (or excessively) of extrinsic regulators such as erythropoietin; low serum erythropoietin is their hallmark. It arises from mutation(s) of a pluripotent hematopoietic stem cell, which results in excess production of erythrocytes and variable overproduction of granulocytes and platelets. In contrast, pegylated interferon- may lead to complete hematologic remission and restoration of polyclonal hematopoiesis in some patients.

Diseases

• Chromosome 19 ring
• Chromosome 2, monosomy 2p22
• Aberrant subclavian artery
• Shapiro syndrome
• Arylsulfatase A deficiency
• Mastoiditis